Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuroblastoma breakpoint family member 8 (NBPF8) is a member of the NBPF gene family located on chromosome 1q21.1[1][2][4]. NBPF genes are characterized by the presence of multiple DUF1220 protein domains, which have undergone significant expansion in humans and are present as segmental duplications. While the specific function of NBPF8 is unknown, copy number variations and altered expression in the NBPF family have been associated with various developmental and neuropsychiatric disorders (including microcephaly, macrocephaly, autism, schizophrenia, and cognitive disabilities) as well as certain cancers such as neuroblastoma. NBPF8 itself is not considered a drug target, and there is no established pharmacological interaction or mechanism of action. The family is notable for containing some pseudogenes, and its evolutionary characteristics may have contributed to human brain development[1][2][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroblastoma breakpoint family member 8 (NBPF8).